These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 31557256)

  • 1. Critically ill patients with community-onset intraabdominal infections: Influence of healthcare exposure on resistance rates and mortality.
    Maseda E; Ramírez S; Picatto P; Peláez-Peláez E; García-Bernedo C; Ojeda-Betancur N; Aguilar G; Forés B; Solera-Marín J; Aliaño-Piña M; Tamayo E; Ramasco F; García-Álvarez R; González-Lisorge A; Giménez MJ; Suárez-de-la-Rica A;
    PLoS One; 2019; 14(9):e0223092. PubMed ID: 31557256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Microbiological and resistance profiles of community acquired and nosocomial intra abdominal infections in surgery of National Hospital Guillermo Almenara, Lima, Peru].
    Revoredo Rego F; Huamán Egoávil E; Zegarra Cavani S; Auris Mora H; Valderrama Barrientos R
    Rev Gastroenterol Peru; 2016; 36(2):115-22. PubMed ID: 27409087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intra-Abdominal Infections: Prevalence and Risk Factors of ESBLs Infections.
    Boontham P; Soontomrak R
    J Med Assoc Thai; 2015 Nov; 98(11):1097-103. PubMed ID: 26817180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiological study of community- and hospital-acquired intraabdominal infections.
    Zhang S; Huang W
    Chin J Traumatol; 2015; 18(2):84-9. PubMed ID: 26511299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monitoring the antimicrobial susceptibility of Gram-negative organisms involved in intraabdominal and urinary tract infections recovered during the SMART study (Spain, 2016 and 2017).
    Cantón R; Loza E; Aznar J; Castillo FJ; Cercenado E; Fraile-Ribot PA; González-Romo F; López-Hontangas JL; Rodríguez-Lozano J; Suárez-Barrenechea AI; Tubau F; Díaz-Regañón J; López-Mendoza D;
    Rev Esp Quimioter; 2019 Apr; 32(2):145-155. PubMed ID: 30761824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial Lessons From a Large Observational Cohort on Intra-abdominal Infections in Intensive Care Units.
    Vogelaers D; Blot S; Van den Berge A; Montravers P;
    Drugs; 2021 Jun; 81(9):1065-1078. PubMed ID: 34037963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Community- and healthcare-associated infections in critically ill patients: a multicenter cohort study.
    Dabar G; Harmouche C; Salameh P; Jaber BL; Jamaleddine G; Waked M; Yazbeck P
    Int J Infect Dis; 2015 Aug; 37():80-5. PubMed ID: 26051976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial susceptibility of pathogens isolated from patients with complicated intra-abdominal infections at five medical centers in Taiwan that continuously participated in the Study for Monitoring Antimicrobial Resistance Trends (SMART) from 2006 to 2010.
    Lee YL; Chen YS; Toh HS; Huang CC; Liu YM; Ho CM; Lu PL; Ko WC; Chen YH; Wang JH; Tang HJ; Yu KW; Liu YC; Chuang YC; Liu CE; Hsueh PR
    Int J Antimicrob Agents; 2012 Jun; 40 Suppl():S29-36. PubMed ID: 22749056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients.
    Kollef MH; Sherman G; Ward S; Fraser VJ
    Chest; 1999 Feb; 115(2):462-74. PubMed ID: 10027448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intermediate risk of multidrug-resistant organisms in patients who admitted intensive care unit with healthcare-associated pneumonia.
    Lee H; Park JY; Lee T; Lee YJ; Lim HJ; Park JS; Yoon HI; Lee JH; Lee CT; Cho YJ
    Korean J Intern Med; 2016 May; 31(3):525-34. PubMed ID: 26968189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiology and susceptibility of pathogens from SMART 2011-12 Turkey: evaluation of hospital-acquired versus community-acquired urinary tract infections and ICU- versus non-ICU-associated intra-abdominal infections.
    Koksal I; Yilmaz G; Unal S; Zarakolu P; Korten V; Mulazimoglu L; Tabak F; Mete B; Oguz VA; Gulay Z; Alp E; Badal R; Lob S
    J Antimicrob Chemother; 2017 May; 72(5):1364-1372. PubMed ID: 28122913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bloodstream infection with extended-spectrum beta-lactamase-producing Enterobacteriaceae at a tertiary care hospital in New Zealand: risk factors and outcomes.
    Freeman JT; McBride SJ; Nisbet MS; Gamble GD; Williamson DA; Taylor SL; Holland DJ
    Int J Infect Dis; 2012 May; 16(5):e371-4. PubMed ID: 22401750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multi-resistant bacteria in spontaneous bacterial peritonitis: a new step in management?
    de Mattos AA; Costabeber AM; Lionço LC; Tovo CV
    World J Gastroenterol; 2014 Oct; 20(39):14079-86. PubMed ID: 25339797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Healthcare-associated, community-acquired and hospital-acquired bacteraemic urinary tract infections in hospitalized patients: a prospective multicentre cohort study in the era of antimicrobial resistance.
    Horcajada JP; Shaw E; Padilla B; Pintado V; Calbo E; Benito N; Gamallo R; Gozalo M; Rodríguez-Baño J; ; ;
    Clin Microbiol Infect; 2013 Oct; 19(10):962-8. PubMed ID: 23279375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial Susceptibilities of Aerobic and Facultative Gram-Negative Bacilli from Intra-abdominal Infections in Patients from Seven Regions in China in 2012 and 2013.
    Zhang H; Yang Q; Liao K; Ni Y; Yu Y; Hu B; Sun Z; Huang W; Wang Y; Wu A; Feng X; Luo Y; Hu Z; Chu Y; Chen S; Cao B; Su J; Gui B; Duan Q; Zhang S; Shao H; Kong H; Badal RE; Xu Y
    Antimicrob Agents Chemother; 2016 Jan; 60(1):245-51. PubMed ID: 26482308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathogen profile and drug resistance analysis of spontaneous peritonitis in cirrhotic patients.
    Li YT; Yu CB; Huang JR; Qin ZJ; Li LJ
    World J Gastroenterol; 2015 Sep; 21(36):10409-17. PubMed ID: 26420967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The healthcare costs of antimicrobial resistance in Lebanon: a multi-centre prospective cohort study from the payer perspective.
    Iskandar K; Roques C; Hallit S; Husni-Samaha R; Dirani N; Rizk R; Abdo R; Yared Y; Matta M; Mostafa I; Matta R; Salameh P; Molinier L
    BMC Infect Dis; 2021 May; 21(1):404. PubMed ID: 33933013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology and clinical features of community-onset bacteremia caused by extended-spectrum β-lactamase-producing Klebsiella pneumoniae.
    Lee JA; Kang CI; Joo EJ; Ha YE; Kang SJ; Park SY; Chung DR; Peck KR; Ko KS; Lee NY; Song JH
    Microb Drug Resist; 2011 Jun; 17(2):267-73. PubMed ID: 21388296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microbiology and resistance in first episodes of spontaneous bacterial peritonitis: implications for management and prognosis.
    Friedrich K; Nüssle S; Rehlen T; Stremmel W; Mischnik A; Eisenbach C
    J Gastroenterol Hepatol; 2016 Jun; 31(6):1191-5. PubMed ID: 26676553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiology of intra-abdominal infection and sepsis in critically ill patients: "AbSeS", a multinational observational cohort study and ESICM Trials Group Project.
    Blot S; Antonelli M; Arvaniti K; Blot K; Creagh-Brown B; de Lange D; De Waele J; Deschepper M; Dikmen Y; Dimopoulos G; Eckmann C; Francois G; Girardis M; Koulenti D; Labeau S; Lipman J; Lipovestky F; Maseda E; Montravers P; Mikstacki A; Paiva JA; Pereyra C; Rello J; Timsit JF; Vogelaers D;
    Intensive Care Med; 2019 Dec; 45(12):1703-1717. PubMed ID: 31664501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.